- Home
- PRME vs WDAY Comparison
PRME vs WDAY Comparison
Compare PRME & WDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- WDAY
- Stock Information
- Founded
- PRME 2019
- WDAY 2005
- Country
- PRME United States
- WDAY United States
- Employees
- PRME N/A
- WDAY N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- WDAY EDP Services
- Sector
- PRME Health Care
- WDAY Technology
- Exchange
- PRME Nasdaq
- WDAY Nasdaq
- Market Cap
- PRME 693.5M
- WDAY N/A
- IPO Year
- PRME 2022
- WDAY 2012
- Fundamental
- Price
- PRME $5.99
- WDAY $237.18
- Analyst Decision
- PRME Buy
- WDAY Buy
- Analyst Count
- PRME 6
- WDAY 29
- Target Price
- PRME $8.88
- WDAY $285.72
- AVG Volume (30 Days)
- PRME 4.2M
- WDAY 3.4M
- Earning Date
- PRME 11-11-2025
- WDAY 11-25-2025
- Dividend Yield
- PRME N/A
- WDAY N/A
- EPS Growth
- PRME N/A
- WDAY N/A
- EPS
- PRME N/A
- WDAY 2.16
- Revenue
- PRME $4,961,000.00
- WDAY $8,959,000,000.00
- Revenue This Year
- PRME $179.58
- WDAY $14.95
- Revenue Next Year
- PRME N/A
- WDAY $12.66
- P/E Ratio
- PRME N/A
- WDAY $109.75
- Revenue Growth
- PRME 739.42
- WDAY 13.94
- 52 Week Low
- PRME $1.11
- WDAY $205.33
- 52 Week High
- PRME $6.94
- WDAY $294.00
- Technical
- Relative Strength Index (RSI)
- PRME 57.76
- WDAY 52.34
- Support Level
- PRME $5.66
- WDAY $232.52
- Resistance Level
- PRME $6.85
- WDAY $241.26
- Average True Range (ATR)
- PRME 0.60
- WDAY 6.70
- MACD
- PRME -0.06
- WDAY -0.49
- Stochastic Oscillator
- PRME 46.49
- WDAY 37.51
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.